Literature DB >> 4674124

Inhibition of monoamine oxidase by substituted hydrazines.

K F Tipton.   

Abstract

1. The initial rate of inhibition of monoamine oxidase by phenethylhydrazine was shown to be similar, in pH-dependence and kinetic properties, to the oxidation of that compound by monoamine oxidase. 2. The time-course of irreversible inhibition of monoamine oxidase by phenethylhydrazine lags behind that of reversible inhibition. 3. Hydralzine was shown to be a reversible competitive inhibitor of monoamine oxidase, but phenylhydrazine is an irreversible inhibitor. Inhibition by the latter compound is not affected by the absence of oxygen, and the presence of substrate exerts no protective action. 4. Hydrazine does not inhibit monoamine oxidase unless a substrate and oxygen are present. 5. Phenethylidenehydrazine was found to be a time-dependent inhibitor of monoamine oxidase and the rate of inhibition was hindered by increasing oxygen concentration. 6. A mechanism for the inhibition of the enzyme by phenethylhydrazine is proposed in which the product of oxidation of this compound is a potent reversible inhibitor and an irreversible inhibitor of the enzyme. A computer simulation of such a mechanism predicts time-courses of inhibition that are in reasonable agreement with those observed experimentally.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4674124      PMCID: PMC1173910          DOI: 10.1042/bj1280913

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.

Authors:  E A ZELLER; S SARKAR
Journal:  J Biol Chem       Date:  1962-07       Impact factor: 5.157

2.  STUDIES ON MONOAMINE OXIDASE: THE MECHANISM OF INHIBITION OF MONOAMINE OXIDASE BY IPRONIAZID.

Authors:  T E SMITH; H WEISSBACH; S UDENFRIEND
Journal:  Biochemistry       Date:  1963 Jul-Aug       Impact factor: 3.162

3.  Some structural considerations regarding compounds that influence monoamine metabolism.

Authors:  B M BLOOM
Journal:  Ann N Y Acad Sci       Date:  1963-07-08       Impact factor: 5.691

4.  Pharmacology of JB-516 (PIH).

Authors:  A HORITA
Journal:  Ann N Y Acad Sci       Date:  1959-09-17       Impact factor: 5.691

5.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

6.  Oxidation of 2-phenylethylhydrazine by monoamine oxidase.

Authors:  K F Tipton; I P Spires
Journal:  Biochem Pharmacol       Date:  1972-01-15       Impact factor: 5.858

7.  The purification of pig brain mitochondrial monoamine oxidase.

Authors:  K F Tipton
Journal:  Eur J Biochem       Date:  1968-03

8.  Mitochondrial monoamine oxidase. II. Action of various inhibitors for the bovine kidney enzyme. Catalytic mechanism.

Authors:  L Hellerman; V G Erwin
Journal:  J Biol Chem       Date:  1968-10-25       Impact factor: 5.157

9.  The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo.

Authors:  B V Clineschmidt; A Horita
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

10.  Molecular aspects of the regulation of rat kidney alkaline phosphatase.

Authors:  F Melani; M Farnararo; V P Chiarugi
Journal:  Biochem J       Date:  1971-01       Impact factor: 3.857

View more
  2 in total

1.  Purification and properties of the trimethylamine dehydrogenase of bacterium 4B6.

Authors:  J Colby; L J Zatman
Journal:  Biochem J       Date:  1974-12       Impact factor: 3.857

Review 2.  Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Authors:  Dmitriy Matveychuk; Erin M MacKenzie; David Kumpula; Mee-Sook Song; Andrew Holt; Satyabrata Kar; Kathryn G Todd; Paul L Wood; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2021-04-10       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.